As obesity rates continue to rise, many are turning to prescription medicines like Ozempic for weight loss. But with ...
The price of Wegovy, the diabetes control drug's glamorous anti-obesity sibling, may also be falling, according to a Health ...
The price of Wegovy, the diabetes control drug's glamorous anti-obesity sibling, may also be falling, according to a Health ...
Novo Nordisk A/S (NYSE:NVO) is a Danish multinational pharmaceutical company that specializes in the discovery, development, ...
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
The biotech industry can be volatile even for relatively large companies. Amgen ( AMGN 1.00%), one of the more prominent names in the game, just reminded us all of that fact. On Nov. 26, the company's ...
Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...
A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...
Most people taking drugs like Ozempic and Wegovy have shed significant pounds. But obesity experts say that roughly 20% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback